Pharma channel feed – Endpoints News

Pharma channel feed

After bagging Shire’s cell therapy castoff, Caladrius stock climbs

8 years ago

Cambridge star Magenta teams up with Heidelberg on bone marrow R&D pact that includes $334M in potential milestones

8 years ago

Stock flies high on Clearside’s PhIII macular edema trial results as drug improves vision

8 years ago

Celgene hands over $101M in cash to launch a research collaboration with protein player Vividion

8 years ago

Unum plays its first glimpse of human data in an $86M IPO, revealing two deaths and an FDA hold

8 years ago

Watch out Endo: Sorrento is after your $1B+ drug with FDA OK of ZTlido

8 years ago

Novartis wants to be a leader in a new generation of prescription digital med programs, pairs with Pear

8 years ago

It’s official: EMA to move into permanent Amsterdam premises in November ‘19 amid continued protests from Italy

8 years ago

J&J collaborates with Aldeyra on new drugs for systemic inflammatory diseases

8 years ago

Sovereign nonsense: Patent board joins the lineup of critics dissing Allergan's 'illusory' IP deal with the Mohawks

8 years ago

FDA provides a long-delayed OK for KemPharm’s opioid — with strings attached

8 years ago

The Trump effect: PwC report says the FDA has slammed the brakes on significant new drug regulations

8 years ago

Hit by an expected EMA rejection, Puma plans to appeal negative opinion on neratinib

8 years ago

Shionogi, Roche get their first approval for the next big thing in fighting the flu

8 years ago

Bristol-Myers axes 107 more staffers as it completes an R&D overhaul

8 years ago

Abandoned by J&J, faded hep C star Achillion axes staff and maps path to PhII readouts

8 years ago

On a journey to find and fuel new biotech ventures, Arix adds France's Ipsen to its network of partners

8 years ago

Takeda commits to a $230M package to seal blockbuster neurological R&D deal with Wave Life Sciences

8 years ago

Amid buzz around a short seller’s FBI visit, MiMedx stock craters following internal investigation

8 years ago

AstraZeneca hauls kidney disease drug into the clinic after handing Ionis $30M in cash, $300M in milestones

8 years ago

Did the FDA just leave the door cracked open for PTC’s Duchenne drug after repeated slapdowns?

8 years ago

AbbVie steers past the wreckage, reserves $224M to kick off once-and-done gene therapy with Voyager to fight Alzheimer’s

8 years ago

White House: Merck and others hit by NotPetya were collateral damage in Russia’s cyberwar on the Ukraine

8 years ago

FDA advisory group rejects Pacira’s pitch for expanded use of pain drug

8 years ago

First page Previous page 306 307 308309310 311 312 Next page Last page